You are here: Industry Insights > vaccinum

News List

J&J, Merck chip in for $100M U.K. vaccine center fiercepharma
December 06, 2018
To help prepare the post-Brexit U.K.—and potentially the world—for future disease outbreaks, the U.K. governmen...
J&J opens €72M vaccine plant for stepped-up R&D fiercepharma
December 04, 2018
Johnson & Johnson has big ambitions in vaccines, and to get there, its manufacturing has to measure up. The small plant acquired in its Crucell purchase just won't support its advancing pipeline candidates—and certainly not product launches down the road.
Dupixent and vaccines bring Sanofi back to growth fiercepharma
November 28, 2018
With competition to its diabetes and cardiovascular franchises hurting Sanofi, CEO Olivier Brandicourt pledged a return to growth starting from the second half of 2018. And thanks mainly to Dupixent and now-recovered vaccines sales, he kept his word.
After scandals, China proposes new fines in bid to shore up domestic vaccine industry fiercepharma
November 28, 2018
After China’s latest vaccine scandal that resulted in more than a dozen arrests and a $1.3 billion fine for a domestic manufacturer, authorities in the country have rolled out proposals to crack down on future vaccine violations.
China proposes new fines for vaccine violations fiercepharma
November 28, 2018
After China’s latest vaccine scandal that resulted in more than a dozen arrests and a $1.3 billion fine for a domestic manufacturer, authorities in the country have rolled out proposals to crack down on future vaccine violations.
Seqirus to spend $140M in N.C. flu vaccine plant expansion pharmaphorum
November 28, 2018
The performance of NHS cancer services in England is lagging behind those of comparable countries, according to a new report.
Emergent and Valneva's Zika vaccine clears phase 1 fiercepharma
November 27, 2018
A Zika vaccine candidate co-developed by Emergent BioSolutions and Valneva has turned up positive early-stage results, laying the groundwork for a potential technology transfer to Emergent.
Emergent and Valneva's Zika vaccine clears phase 1 fiercepharma
November 22, 2018
A Zika vaccine candidate co-developed by Emergent BioSolutions and Valneva has turned up positive early-stage results, laying the groundwork for a potential technology transfer to Emergent.
World Polio Day: on the cusp of eradication pharmaceutical
November 19, 2018
World Polio Day was established on the birthday of the creator of the first polio vaccines, Jonas Salk, to focus on educating and informing the world about polio and the success GPEI had had in eradicating the disease on a global scale.